期刊文献+

血清降钙素原在急性发热疾病诊断中的价值 被引量:3

The Diagnostic Value of Procalcitonin in Patients with Acute Febrile Disease
下载PDF
导出
摘要 目的:探讨血清降钙素原在急性发热疾病诊断中的价值。方法:研究对象为急性发热患者87例,其中细菌感染组49例,病毒感染组38例,另选正常对照组35例,通过检测三组血清降钙素原水平,对比各组患者治疗前血清降钙素原水平,并检测使用抗生素3-5天后患者血清中降钙素原水平。结果:治疗前细菌感染组患者血清降钙素原水平显著高于病毒感染组和正常对照组(P均<0.05),病毒感染组与正常对照组血清降钙素原无统计学差异(P=0.075);细菌感染组在抗生素治疗3-5天后血清降钙素原水平显著低于治疗前水平(P<0.001)。结论:降钙素原的检测对急性发热患者病因诊断有一定的临床价值,并能评估细菌感染的治疗预后。 Objective: To investigate the diagnostic value of procalcitonin in patients with acute febrile disease. Methods:We recruited 87 patients with acute febrile disease including 49 patients with confirmed diagnosis of bacterial infection and 38 patients with virus infection. In addition, 35 healthy volunteers were included. Serum procalcitonin was detected in all the subjects. The serum procalcitonin was compared among the three groups. The levels of procalcitonin in bacterial infection group were also evaluated after 3-5 days antibiotic treatment. Results: The level of procalcitonin in patients with bacterial infection was significantly higher than that in virus infection group and the control group (all P 〈 0.05).There was no significant difference between the virus infection group and the control group (P = 0.075). After 3-5 days antibiotic treatment, the levels of procalcitonin in bacterial infection group was decreased significantly (P 〈 0.001 ). Conclusions: Serum procalcitonin has a certain value in the differential diagnosis of acute febrile disease and predicts the prognosis and treatment.
出处 《岭南急诊医学杂志》 2014年第1期24-25,共2页 Lingnan Journal of Emergency Medicine
关键词 降钙素原 发热性疾病 诊断 procalcitonin febrile disease diagnosis
  • 相关文献

参考文献7

二级参考文献138

  • 1Bone RC,Balk RA,Cerra FB. ACCP/SCCM definitions for sepsis and organ failure guidelines for the use of innovative therapies in sepsis[J]. Chest, 1992,101:1644- 1655.
  • 2Joan M. The role of C reactive protein in the evaluation and management of infants with suspected sepsis[J].Adv Neonatal Care,2003,3(1):3 -13.
  • 3Povoa P, Almeida E, Moreira P,et al. C-reactive protein as an in dicator of sepsis[J]. Intensive Care Med, 2008, 24: 1052-1056.
  • 4Claeys R,Vinken S,Spapen H,etal. Plasma procalcitonin and C- reactive protein in acute septic shock: clinical and biological corerlates[J]. Crit Care Med, 2002,30(4) :757-762.
  • 5Haweky PM. Mechanisms of resistance to antibiotics[J]. In tensiev Caer Med, 2000,26 : 9 -13.
  • 6Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101 (6):1644-1655.
  • 7Guérin S.Evaluation of the detection of procalcitonin by an immuno-chromatography test:Brahms PCT-Q[J].Ann Biol Clin (Paris),2000,58(5):613-614.
  • 8Assicot M,Gendrel D,Carsin H,et al.High serum procalcitonin concentrationa in patients with sepsis and infection[J].Lancet,1993,341 (8844):515-518.
  • 9Meisner M,Lohs T,Huettemann E,et al.The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function[J].Eur J Anaesthesiol,2001,18(2):79-87.
  • 10Oshita H,Sakurai J,Kamitsuna M.Semi-quantitative procalcitonin test for the diagnosis of bacterial infection:clinical use and experience in Japan[J].J Microbiol Immunol Infect,2010,43(3):222-227.

共引文献952

同被引文献18

  • 1Limper M, de Kruif MD, Duits AJ, et al. The diagnostic role of proealcitonin and other biomarkers in discriminating infectious from non-infectious fever [J]. J Infect,2010,60(6):409-416.
  • 2Maller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumo- nia:a prospective cohort trial [J]. Chest,2010,138(1) :121-129.
  • 3Kordek A, Torb6 A, Podraza W, et al. Does prenatal antibiotic therapy compromise the diagnosis of early-onset infection ana management of the neonate [J]. J Perinat Med,2011,39(3):337 342.
  • 4Beckcr KL, Snider R, Nylen ES. Procaleitonin in sepsis and sys- temic in{lammation:a harm{ul biomarker and a therapeutic target [J]. Br J Pharmaeol, 2010,159(2) : 253-264.
  • 5Riedel S, Melendez JH, An AT, et al. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency de- partment [J]. Am J Clin Pathol,2011,135(2) :182-189.
  • 6Kim MH, Lira G, Kang SY, et al. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever [J]. Yonsei Med J,2011,52(2) :276-281.
  • 7毛晓露,李归宁.血清降钙素原和血清前清蛋白在呼吸道感染性疾病中的应用[J].国际检验医学杂志,2011,32(8):843-844. 被引量:43
  • 8赵军育,姜毅,侯新琳.降钙素原在诊断早期新生儿感染中的意义[J].实用儿科临床杂志,2012,27(2):122-124. 被引量:48
  • 9徐志锋,余梅娟,李志全,陈荣健,李国明.血清降钙素原及超敏C-反应蛋白在急性发热患者诊断中的应用[J].河北医学,2013,19(5):669-672. 被引量:10
  • 10赵立杰,谢云,王翠霞,张力,李敏娟,田利永,赵卓华.降钙素原水平在诊治发热患者中的临床价值[J].现代中西医结合杂志,2013,22(19):2131-2133. 被引量:4

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部